Ingrédients et solutions pour l’industrie alimentaire
Micro-organismes et principes actifs pour la santé humaine
Ferments lactiques pour le secteur agro-vétérinaire

SYNBIO: Sacco System’s probiotic support for healthy ageing

04/09/2026

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy and active as we grow older is becoming increasingly important, especially considering that more than 50% of the global disease burden in adults is linked to age-related conditions.

As we age, our bodies tend to develop a state of low-grade, chronic inflammation known as “inflammaging”, and the composition of the gut microbiota changes significantly. Diet, lifestyle and age-related physiological changes promote a condition of gut dysbiosis which, together with inflammaging, can contribute to frailty, loss of function and a higher risk of disease.

In this scenario, Sacco System presents SYNBIO, a clinically studied probiotic blend designed to help counteract processes linked to inflammaging and support healthy ageing. SYNBIO is part of the CultureScience portfolio, a selection of clinically validated probiotic strains strategically formulated to address key health needs across different life stages. These solutions are available both as single strains and as pre-formulated blends, all evaluated in gold-standard clinical trials that confirm their efficacy.

Probiotic supplementation is gaining attention for its role in maintaining health and enhancing the quality of life of the elderly. Leukocyte Telomere Length (LTL) is a biomarker of cellular ageing, with shorter LTL associated with cardiovascular morbidity and mortality. This study explored whether probiotics could counteract LTL attrition in an ethnically homogeneous cohort of older adults over a six-month period. 

Samples were selected from the PROBIOSENIOR trial, a randomized, double blind, placebo-controlled study involving 46 participants (≥60 years). Participants were randomized to receive either SYNBIO probiotics (5×10⁹ CFU/daily dose) or placebo for six months. Genomic DNA was extracted from blood samples at baseline, and six months later; LTL measures were obtained via quantitative PCR. A general linear model assessed the “treatment x time” interaction as the main outcome. 

LTL was successfully assessed for all participants (N= 46×2 time points). Statistical analysis revealed a significant “treatment x time” interaction (P=0.034), indicating a reduced LTL attrition rate in the probiotic group compared to the placebo group. 

A six-month supplementation with SYNBIO probiotics significantly reduced LTL attrition in an ethnically homogeneous cohort of elderly adults. These findings suggest that probiotics may serve as a simple and effective intervention to mitigate cellular senescence and promote healthy ageing. 

The growing global burden of age-related conditions highlights the need for safe, accessible strategies that support healthy ageing. Ageing is accompanied by profound changes in gut microbiota composition and a chronic inflammatory state known as inflammaging, both of which contribute to physiological decline and increased disease risk. In this context, the SYNBIO probiotic blend offers a promising approach to help counteract these processes. Findings from the PROBIOSENIOR clinical study demonstrate that six months of SYNBIO supplementation can significantly reduce leukocyte telomere length attrition, suggesting a beneficial effect on cellular ageing. Together with its documented anti-inflammatory potential, SYNBIO represents a compelling candidate for innovative formulations designed to maintain physiological resilience, promote longevity, and enhance quality of life in older adults. 

SYNBIO is a natural ingredient that supports healthy ageing; improves inflammaging through modulation of the gut microbiota and the SCFA pool.  Supplementation with SYNBIO may modulate key biomarkers of sarcopenia in elderly subjects and improve the nutritional status of the elderly, reducing the risk of malnutrition. 

In a constantly evolving global market, innovation represents the key driver of competitiveness and sustainability. Sacco System is a pioneer of innovation in the field of lactic acid bacteria and food biotechnology. Drawing on deep scientific expertise, Sacco System integrates technological innovation (from applied genomics and microbial strain engineering to advanced production processes) with product innovation, offering customized solutions that meet consumer needs for taste, health, and well-being. 

The company succeeds in translating cutting-edge research into successful final products, helping to redefine quality standards and promote a more efficient, safe, and sustainable food industry. All of this is made possible through a strong focus on technological and process innovation, sustainability, and the development of human capital. 

Read the full study here: https://pubmed.ncbi.nlm.nih.gov/41335484/

Latest news

19 mars 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

20 novembre 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 février 2025
Lacticaseibacillus rhamnosus CA15 Achieves GRAS Status: A Milestone for Women's Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 janvier 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 novembre 2024
News, News
Notre rapport de développement durable 2023 est on-line!

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…

16 avril 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the

26 mars 2024
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco

18 mars 2024
List Biotherapeutics and Sacco System Announce Lead Share Agreement

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce

26 février 2024
News, News
CSL FRANCE devient SACCO SYSTEM FRANCE

Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…

21 février 2024
Sacco System Supports Action4Diabetes' mission

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,

19 février 2024
Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration

06 décembre 2023
Sacco System launches the new Ingredients website

Sacco System is pleased to announce that the new website ingredients.saccosystem.com is now online. INgredients is a project launched in 2020 with the aim of making the hidden world of